Marshall Wace, LLP Sio Gene Therapies Inc. Transaction History

Marshall Wace, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.29 - $2.36 $61,322 - $112,187	-47,537 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.81 - $2.7 $86,041 - $128,349	47,537 New	47,537 $103,000
Q1 2021 May 17, 2021	SELL	$2.34 - $3.44 $143,636 - $211,157	-61,383 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.91 - $5.63 $117,241 - $345,586	61,383 New	61,383 $171,000

147K

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.